Skip to main content

Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model

Abstract

Background

Sub-Saharan Africa (SSA) experiences disproportionate burden of cervical cancer incidence and mortality due in part to low uptake of cervical screening, a strategy for prevention and down-staging of cervical cancer. This scoping review identifies studies of interventions to increase uptake of cervical screening among women in the region and uses the Integrated Behavioral Model (IBM) to describe how interventions might work.

Methods

A systematic search of literature was conducted in PubMed, Web of Science, Embase, and CINAHL databases through May 2019. Screening and data charting were performed by two independent reviewers. Intervention studies measuring changes to uptake in screening among women in SSA were included, with no restriction to intervention type, study setting or date, or participant characteristics. Intervention type and implementation strategies were described using behavioral constructs from the IBM.

Results

Of the 3704 citations the search produced, 19 studies were selected for inclusion. Most studies were published between 2014 and 2019 (78.9%) and were set in Nigeria (47.4%) and South Africa (26.3%). Studies most often assessed screening with Pap smears (31.6%) and measured uptake as ever screened (42.1%) or screened during the study period (36.8%). Education-based interventions were most common (57.9%) and the IBM construct of knowledge/skills to perform screening was targeted most frequently (68.4%). Willingness to screen was high, before and after intervention. Screening coverage ranged from 1.7 to 99.2% post-intervention, with six studies (31.6%) reporting a significant improvement in screening that achieved ≥60% coverage.

Conclusions

Educational interventions were largely ineffective, except those that utilized peer or community health educators and mHealth implementation strategies. Two economic incentivization interventions were moderately effective, by acting on participants’ instrumental attitudes, but resulted in screening coverage less than 20%. Innovative service delivery, including community-based self-sampling, acted on environmental constraints, striving to make services more available, accessible, and appropriate to women, and were the most effective. This review demonstrates that intent to perform screening may not be the major determinant of screening behavior, suggesting other theoretical frameworks may be needed to more fully understand uptake of cervical screening in sub-Saharan Africa, particularly for health systems change interventions.

Peer Review reports

Background

Cervical cancer is among the most common cancers worldwide and disproportionately affects African women [1]. As Africa experiences an epidemiologic transition, with aging populations that are susceptible to lifestyle diseases, the continent accounts for an increasing proportion of global cancer cases and deaths. Regional variations in cervical cancer are especially marked; Sub-Saharan Africa has the highest rates of cervical cancer in the world and cervical cancer is the number one cancer-related cause of mortality in the region [2]. The age-standardized mortality rate in East Africa is 30.0 per 100,000 compared to just 1.9 per 100,000 in North America, almost a 16-fold higher rate [2]. Incidence, similarly, is six times higher in East Africa than North America (40.1/100,000 vs. 6.4/100,000) [2].

Most cervical cancer is caused by Human Papillomavirus (HPV) infection, a common and often asymptomatic sexually transmitted infection. As a disease with both infectious and non-infectious etiologic components and risk factors, such as an increased risk for cervical cancer among women living with HIV, the cervical cancer epidemic in Africa is both profound and complex. The African cervical cancer epidemic is characterized by the double burden of communicable and non-communicable disease [3], human resource for health shortages [4], preventive health service delivery challenges [5,6,7], lack of access to treatment, and low cervical cancer awareness among the population and health providers [8, 9].

Since cervical cancer is a preventable cancer, screening is an important cancer control and prevention strategy, recommended by the World Health Organization (WHO) for all women aged 30 years and older, and beginning even earlier for some high-risk groups such as women living with HIV [10]. Many African countries have adopted a “screen-and-treat” approach in recent years, aimed at employing routine screening of asymptomatic adult women for early detection and on-the-spot treatment of cervical pre-cancerous lesions. Due to resource and infrastructure constraints, cytology-based screening methods like Pap smears may not be feasible for some African communities or may cause service delivery bottlenecks that prevent screening programs from achieving high coverage. Alternatively, visual inspection of the cervix with acetic acid (VIA) or Lugol’s iodine (VILI) may provide a low-cost screening alternative that can be implemented by various cadres of trained health workers [5, 6, 10]. Additional screening methodologies include HPV testing, which can utilize provider-collected or patient-collected sampling techniques. Still, uptake of screening services remains low in Africa [6], with women citing barriers of fear of the procedure and outcomes, cultural issues such as stigmatization, breach of modesty, inaccessibility of screening services, and a view that screening services are unnecessary if one is feeling well [8].

The aim of this scoping review is to map the literature on interventions to increase uptake of cervical screening in sub-Saharan Africa and identify opportunities for future intervention development and research. The Integrated Behavioral Model (IBM) is applied as a health behavior framework to understand how interventions might work to improve screening behavior.

Methods

This scoping review was conducted from April to October 2019, utilizing a rigorous systematic search of four electronic publication databases, a structured two-step screening process conducted by multiple independent reviewers, and an iterative data charting process that employed the IBM to describe the nature of interventions conducted to increase cervical cancer screening among women in sub-Saharan Africa. Given the wide range in approaches to increasing cervical cancer screening, the many different screening methods being practiced and evaluated, and the goal of identifying gaps in knowledge through mapping to a behavior change model, we determined scoping methodology was best suited for this review [11, 12]. Findings are reported according to Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist [13].

Search and screening

A medical librarian (JMC) was consulted to develop a comprehensive search strategy, to identify appropriate databases, and to conduct the literature search. We systematically searched electronic databases PubMed/MEDLINE (1946-May 1, 2019), Clarivate Analytics Web of Science (1900-May 1, 2019), Elsevier EMBASE (1947-May 1, 2019), and EBSCO CINAHL (1982-May 1, 2019). The searches utilized controlled vocabulary searching modified for each database, as well as natural or key terms following a structure of “topic/cervical cancer” AND “outcome/screening uptake” AND “context/population.” No language or publication date restrictions were applied. Additional file 1: Appendix 1 details the complete search strategy. Conference proceedings and abstracts, published as supplements to journals or indexed in the electronic databases, were returned in the search and were screened with the same eligibility criteria as peer-reviewed articles.

The search results were compiled and deduplicated using EndNote (version × 8). Then, the deduplicated entries were uploaded to Covidence, an online software for systematic screening of results. Screening was completed in two rounds: title and abstract screening was performed, then full text review for eligibility. Each search result was screened independently by two reviewers (BEL, MJT, CB). If the two reviewers were not in agreement, the result was screened by a third reviewer (BEL, MJT, CB).

Eligibility criteria

Inclusion criteria were studies with an intervention component, conducted in a sub-Saharan African community, and any type of participant such as women, their male partners or other family members, or health care providers. Studies were excluded if they targeted African participants in a non-African setting as were studies measuring attendance of follow-up care for women who had previously attended cervical cancer screening. All intervention types were considered including one-on-one or group educational interventions or counseling, patient reminders, media and awareness-building campaigns, incentivization schemes, and innovative service delivery approaches, which could be set in health facility- or community-based contexts. The primary outcome of interest was uptake of cervical screening, measured as self-reported or medically verified receipt of any type of cervical cancer screening service, as a proportion of the entire study population. Secondary outcomes of interest were cervical cancer or screening knowledge/awareness, willingness/intent to get screened, and cervical cancer or screening-related attitudes/beliefs. Comparisons varied and included no intervention and standard care. Study designs that could demonstrate a change in screening uptake over time or between two groups were included: randomized control trials, observational cohort studies, and before-and-after studies. Studies that described screening program implementation, without screening rates for a comparison group were excluded.

Data charting and analysis

An excel data charting form, created and tested by our team, was used to elicit information on pre-defined variables from the included sources. The form was modified during an iterative data charting process. Data extracted included: study period, location, sample size, aims of the study, methodology, participants/population, intervention, comparison, findings, and author recommendations. In addition to descriptions of the intervention, information was recorded about the intervention development process and the delivery. Data charting for each included study was completed by two reviewers (BEL, MJT, CB). Reviewers used emergent themes to categorize the studies by intervention type. Content analysis was performed, using the IBM as a framework to describe the scope of interventions included, as described in the following section. Each study was reviewed for evidence that the researchers considered IBM constructs during the development of their intervention, as the mechanism through which the intervention is supposed to act, or as a measure or outcome of the intervention study. Presence or absence of IBM constructs was recorded for each study and the compiled construct frequency data is presented in a table. Narrative synthesis is used to elaborate on ways in which the constructs appeared in the included studies. An optional quality assessment of the included studies was not performed, as it is unnecessary for scoping review methodology and did not help us to meet our study objectives [11].

Integrated behavioral model

As the purpose of this review is to describe the nature of interventions that have been conducted to increase uptake of cervical cancer, we chose to use a health behavior model to map the breadth of literature, to understand how the interventions might work to create behavior change, and to identify gaps in intervention types and implementation strategies that have been attempted. The IBM was developed by bringing together constructs from the Theory of Planned Behavior, the Theory of Reasoned Action, and other prominent health behavior theories with overlapping constructs [14]. The main premise of the IBM is that the most important determinant of a behavior is intention to perform that behavior, and that intention is influenced by attitudes, perceived norms, and personal agency [14]. Factors such as knowledge and environmental constraints also act on the behavior directly (see Fig. 1). This review uses the IBM to understand cervical screening as a behavior, “willingness to screen” as the precursive intention to perform the screening behavior, and other theoretical constructs to describe the rationale, action, and evaluation of interventions intended to change screening behavior.

Fig. 1
figure1

The Integrated Behavioral Model (IBM), adapted for cervical cancer screening behavior

Results

Study characteristics

The systematic search returned 3704 unique entries, after duplicates were removed. Screening and application of eligibility criteria produced 19 studies for inclusion in the review [15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. Figure 2 shows the results of the study selection process. The majority of studies were published between 2014 and 2019 (n = 15, 78.9%), and were randomized (n = 9, 47.4%) or quasi-experimental studies (n = 5, 26.3%). Studies were set in seven African countries with almost half set in Nigeria (n = 9, 42.9%), followed by South Africa (n = 5, 23.8%) and Kenya (n = 3, 14.3%). While not all studies specified, both urban and rural settings were represented. Minimum age eligibility criteria were used to define target populations; few studies cited World Health Organization or other screening recommendations when defining age criteria. Pap smear or cytology-based cervical screening was assessed most often (n = 6, 31.6%) [16, 17, 21, 26, 31, 33]. A quarter of studies (n = 5, 26.3%) did not specify which screening test was being performed [20, 22, 24, 29, 32]. Multiple screening methods were used in some studies, such as those that compared uptake of HPV self-sampling to facility-based visual inspection screening methods [19, 25, 27, 28]. Screening was offered at workplaces [28], in women’s homes [19, 27, 28], in community spaces [23], and in health facilities [15,16,17,18, 20,21,22, 24,25,26, 29,30,31,32,33]. Study characteristics are presented in Table 1.

Fig. 2
figure2

Flow diagram of source selection process

Table 1 Descriptive statistics of study period, context, and methodology of included studies

We found three emergent themes for intervention types: health education interventions (n = 11, 57.9%), economic incentivization interventions (n = 2, 10.5%), and innovative service delivery interventions (n = 6, 31.6%). Descriptions of the population, intervention, comparison, and outcomes (PICO) of included studies, organized by intervention type, can be found in Table 2. The most prevalent type of intervention was health education which was characterized by use of short-term, lecture-based education, peer health educators, multimedia lessons, and behavior change communication and message framing interventions. Educational interventions operated under the rationale that low knowledge and awareness of cervical cancer and screening services are the primary barriers to screening uptake. These interventions were implemented in-person and remotely, through email and text messaging. There were two economic incentivization interventions, which included a lottery-style game that was played by women to randomize their households to receive subsidized cervical screening and cancer treatment in the unlikely event that cancer was detected and a reward program offered by a health insurance plan that incentivized receipt of preventive health services including cervical screening, where women could earn points and prizes for their behavior [26, 30]. Six of the included studies described innovative approaches to delivering cervical screening including: changes to the type of cervical screening provided, the screening location, or the coupling of cervical screening with other services with the intent to make cervical screening more comfortable, convenient, and accessible by removing or mitigating environmental barriers to screening. Cervical screening was integrated with sexual and reproductive health services in two studies [22, 24], and with HPV vaccination for adolescent daughters in a school-based intervention [19]. Multiple studies also drew upon established social ties; interventions targeted male partners [22] and peer groups of female sex workers [24], utilized trusted community health outreach workers and religious leaders to deliver interventions [18, 25, 28], and leveraged the influence of the King’s council in one community [27].

Table 2 Description of interventions to increase uptake of cervical screening in sub-Saharan Africa and related outcomes

Effectiveness of interventions: screening uptake

Uptake of cervical screening was most commonly measured as “ever screened” (n = 8, 42.1%) or screened in a specified amount of time, usually during the study period (n = 7, 36.8%). One study created a screening score that accounted for presence of screening behavior, as well as when screening was last received and whether or not a woman was up-to-date with screening recommendations [19]. Some studies used vague language to describe uptake of cervical screening, which made it impossible to clearly deduce the measure of screening [16, 22, 28, 29, 32]. At baseline, screening coverage ranged from 0 to 53.6%, with most studies reporting coverage of less than 10% (n = 12, 63.2%). Following intervention, coverage ranged from 1.7 to 99.2%, with six studies reporting a significant improvement in screening that achieved ≥60% coverage (31.6%). More than a third of the studies reported non-significant increases in screening uptake associated with their intervention (n = 7, 36.8%); all of them were educational interventions [16, 17, 21, 29, 31,32,33].

One educational intervention was particularly effective, with a 64.4 percentage point increase in “ever screened” from 3.2% pre-intervention to 67.6% screened post-intervention (p < 0.001) [18]. This study evaluated a house-to-house education program that provided women with information about cervical and breast cancer and offered free screening services at health facilities within walking distance as well as HPV vaccination for eligible children for a fee. Two other educational interventions resulted in more modest, but significant improvements in coverage. One was an SMS behavior change communication intervention, offered with and without additional eVouchers to cover transportation costs to the screening clinic. Women who received the 15 SMS messages over 21 days had three times greater odds of screening during the study period than women in the control group (12.9% uptake vs. 4.3%, adjusted odds ratio [AOR] = 3.0, 95% CI: 1.5–6.2) [20]. Women randomized to receive the eVoucher for transportation in addition to the behavior change communication had almost five times the odds of uptake compared to the control group (18% uptake vs. 4.3%, AOR = 4.7, 95% CI: 2.93–7.44) [20]. Mbachu et al. designed a health education intervention that trained clergy wives in Anglican dioceses to deliver peer health education on cervical cancer to women they worship with. Women attending at least three group sessions reported a 6.8 percentage point increase in “ever screened” from 10.5% pre-intervention to 17.3% post-intervention (p = 0.02) [25].

As a category, the interventions that used innovative approaches to cervical cancer service delivery provided the most compelling results. A pilot RCT with 500 women in Uganda found that use of outreach workers to distribute and collect HPV self-sampling kits from women in their homes and workplaces was highly effective; 99.2% of self-collection samples were returned for HPV testing [28]. The control group, which received outreach worker visits, appointments for VIA screening at the local health facility, and phone call reminders the day before the appointment, also had good uptake (48.4%) [28]. The use of outreach workers was an effective screening implementation strategy and the use of self-sampling as the intervention further increased the uptake of screening behavior. Another study of home-based HPV self-sampling in Nigeria resulted in similar outcomes with 92.5% uptake in the intervention group post-intervention and 56.5% uptake in the control group post-intervention, compared to 1.5 and 1% uptake respectively in each group pre-intervention [27]. One study in rural Kenya offered community-based HPV screening at pop-up tents during a two-week phase of a six-week community health campaign. Women who screened on-the-spot in the tents had 60% uptake compared to the control community where women were referred to their local government health facility for testing, resulting in 37% uptake [23]. Another approach was to offer cervical screening as an add-on service for patients and their partners who were already seeking care in a facility. In a large RCT in urban Zambia, Hewett et al. offered enhanced client-centered counseling, referral to add-on services, and follow-up by phone if the appointment was missed [22]. Additionally, a second intervention group was provided escort services from the original service to the referral service location. A significant increase in the uptake of cervical screening was observed for both intervention arms compared to standard of care (without escort: 22.2% vs. 9.7%, AOR 2.75, 95% CI: 1.94–3.91; with escort: 23.6% vs. 9.7%, AOR = 2.98, 95%CI: 2.10–4.22) [22]. Another integrated services intervention targeted female sex workers in South Africa, Mozambique, and Kenya [24]. Implementation looked different in each site with shared components of increasing access to general health facilities, targeted peer outreach, targeted clinical services, and female sex worker empowerment. Significant increases in uptake were observed in South Africa (31.8 to 60.0%, p = 0.001) and Mozambique (0 to 25.2%) [24]. Lastly, combining cervical screening with a school-based HPV vaccination program in South Africa increased screening among mothers to 68.9%, though the prevalence of “ever screened” was higher at baseline (53.6%) compared to other included studies [19]. Both self-sampling and facility-based screening were offered with this intervention; a more favorable change was observed for the self-collection group with 45.3% of the screening kits being returned for testing [19].

Secondary outcomes

Almost half of the included studies assessed some outcome other than screening uptake (n = 9, 47.4%): six had some measure of awareness (31.6%) [15, 18, 21, 29, 32, 33], five measured knowledge (26.3%) [15, 16, 19, 29, 32], one included an attitude score [16], and four reported “willingness to screen” (21.1%) [15, 25, 29, 33]. No studies used a validated measure for any of the secondary outcomes. Generally, improvements in secondary outcomes were observed, even when cervical screening did not significantly improve (Table 2). Willingness to screen was high before and after interventions, ranging from 63.4 to 89.7% of participants at baseline to 80.8 to 92.3% at follow-up.

Theory of cervical screening behavior change

Theoretical frameworks were cited by several of the included studies, including the Health Belief Model [20], Pender’s Health Promotion Model [29], Behavior Change Theory [32], Prospect Theory [17], Diffusion of Innovation Theory [25], and the Intertemporal Choice Problem [26, 30]. We analyzed all included studies by applying the IBM and assessing whether IBM constructs were considered during intervention development, as the intervention mechanism, or as a measure/outcome of the intervention (Table 3). Knowledge and skills to perform the behavior was the construct considered most often (n = 13, 68.4%) followed by environmental constraints (n = 10, 52.6%). These constructs align with the intervention categories of educational interventions and innovative service delivery interventions, presented in Table 2. Economic incentivization interventions acted on the construct of instrumental attitude and operated under a premise that individuals must weigh the perceived costs/consequences and benefits of cervical screening and that behavior change can be prompted by increased immediate benefit or reduced cost of screening. Measures of instrumental attitude included individual risk assessments and perceived severity of cervical cancer. In addition to economic incentives, motivational interviewing was used to act on the construct of instrumental attitude, by helping patients to express and overcome individual barriers to screening and to improve self-efficacy [22]. Interventions employing peer or community health education acted on perceived norms (injunctive norms), in addition to providing knowledge to perform the behavior [18, 22, 24, 25]. Other strategies targeting norms included use of culturally-relevant media to disseminate information or demonstrations that modelled cervical cancer screening behavior [15, 16, 31].

Table 3 Number of studies addressing Integrated Behavior Model (IBM) constructs to increase uptake of cervical screening

Studies assessed experiential attitudes like fears and misconceptions about cervical screening when developing interventions that would be contextually-appropriate to their populations, and measured experiential attitude following interventions through acceptability questions like “was screening straight-forward/comfortable/convenient?” [23, 27]. Participants reported that screening methods were acceptable, indicating the experiential attitudes toward cervical cancer screening were positive overall. They would also recommend screening to friends, indicating positive descriptive norms (99.4 and 99.0% of self-sampling intervention arms) [23]. Salience of behavior could not be measured for women receiving screening for the first time but agreement with the statement that they would screen again in the future and future screening preferences indicate support for salience [23, 27]. Perceived control, a construct of personal agency, was measured by five studies that asked participants to identify barriers to screening [15, 16, 25, 29, 33]. Lack of awareness of screening services was unanimously the greatest perceived barrier to screening pre-intervention or in the control group among the five studies that measured participants’ perceived control and ranged from 41.4 to 94% [15, 16, 25, 29, 30]. For women participating in interventions, there was a shift following the intervention to citing other reasons for not screening which included lack of access or availability of screening services [15, 29], no symptoms/low perceived risk [25, 33], or not liking the test (Pap smear) [15]. Intention to perform the behavior or “willingness to screen” was measured by four of the studies (21.1%). Intention was high, even prior to intervention, with all four studies reporting that more than 70% of women were hypothetically willing to screen [15, 25, 29, 33].

Discussion

Educational interventions were the most common type of intervention used to increase uptake of cervical screening in sub-Saharan Africa. The rationale for educational interventions is consistent with previous literature that names lack of knowledge or awareness as the most common barrier to cervical screening in low-and-middle-income countries and another review that found educational strategies were the most common among all cancer prevention efforts in sub-Saharan Africa [34, 35]. Educational interventions were not very effective overall. However, the studies that utilized peer health educators or community health educators as part of the implementation strategy were an exception [18, 25]. One of these studies provided one-time house-to-house education while the other required continued, on-going group engagement in a religious community setting. Both emphasized the role of social ties, using educators that were already known to the study participants. The SMS behavior change communication intervention also had modest but significant improvements in screening during the study period, with and without eVouchers provided for transportation, demonstrating that mHealth interventions may provide opportunity for future efforts to improve screening uptake especially as mobile phone ownership continues to grow, and that such approaches can be improved by adding interpersonal elements [20]. Invitations to screen and use of lay health advisors are two strategies that have been previously demonstrated to improve cervical screening behavior outside of SSA [36,37,38]. Educational interventions may also work when they are intensive, culturally-appropriate, based on health behavior models, and multi-dimensional so that they help women to overcome environmental constraints [36, 38]. Interventions that were not effective were short-term or one-time educational interventions, use of a photo-comic to deliver education, and framing of email messages.

Economic incentivization interventions were moderately effective, increasing uptake but still achieving less than 20% coverage [26, 30]. With only two studies incentivizing screening, there is also a paucity of evidence for this intervention type. Removing costs and increasing women’s perceived benefits of screening does lead to increased uptake of screening, but the low post-intervention coverage indicates that further action is needed to reach desirable coverage. This approach may be combined with other types of interventions in the future, like those that consider environmental constraints and act on instrumental attitude simultaneously. Several studies did include eVouchers to cover transportation costs, or purposely selected communities where screening was available within walking distance, which may be a best practice. This claim is supported by the finding that a 10-min increased travel time to the clinic reduced participation by 1.5 percentage points in one study [30], that “distance to the screening center” was identified as a barrier to screening post-intervention by 16.2 and 21.6% of women in two other studies [25, 29], and that eVouchers for transportation, when added to an SMS messaging intervention, increased odds of screening compared to the intervention without eVouchers for transportation (AOR: 1.53, 95% CI: 1.11–2.19) [20].

Innovative service delivery interventions worked by changing the location of screening services, or by combining screening services with other health services such as voluntary male circumcision and HPV vaccination. The six studies in our review that were categorized as innovative service delivery approaches focus on the availability, accessibility, and appropriateness of screening services for women, acting on the IBM construct of environmental constraints. Categorically, these interventions resulted in the greatest increases in screening uptake.

Appropriateness of IBM to explain cervical screening

The IBM operates on the premise that behavior is most influenced by the intent to perform that behavior. In this review, we observed very high willingness to screen, even pre-intervention, but that intent was not always well-translated to uptake of cervical cancer screening. Ndikom et al. described an increase from 75.8 to 91.0% in willingness to screen yet no change in actual screening [29]. Furthermore, one of the included studies saw a significant improvement in uptake without any significant change in willingness to screen [25]. Through application of the health behavior model, we can begin to examine how interventions may work and explore other factors that may be disrupting the translation of behavioral intent to behavior. For example, intention may not translate to desired behavior when knowledge or skills to perform the behavior are low or when environmental constraints prevent a person from following through on the intent. Two educational interventions found that after intervention, participants were less likely to identify knowledge or awareness as a barrier to screening but more likely to identify non-availability of services [15, 29]. The reality is that low awareness and availability issues probably need to be addressed concurrently. We suggest more research into health systems change interventions that address infrastructure and human resource challenges, patient-centered healthcare delivery, and reducing “visit burden” for patients and facilities. While these types of interventions act on the environmental constraints construct of the IBM, another theoretical framework may be more appropriate for systems change interventions where individual behavioral intention is not the major determinant of behavior change.

Habit related to the behavior of cervical screening was not considered by any of the studies, likely because the goal of most interventions was to get women to screen for the first time rather than to instill a new habitual health behavior. Two studies assessed intended salience of behavior by asking participants if they would test again in the future and what their preferences would be [23, 27]. Very few interventions considered the element of self-efficacy, perhaps in part because of the focus on environmental constraints beyond a patient’s control, rather than internal factors. Techniques like motivational interviewing, in combination with the removal of environmental constraints may be one way to increase women’s personal agency and should be explored through future research as a method of improving uptake.

Interventions that target male partners and families as an opportunity

One included study involved males, by offering referral services to patients and their partners seeking care at facilities in the study catchment area [22]. This intervention offered cervical screening as an add-on service for all women seeking care and for female partners of all men seeking care. Male partners of females seeking care were also referred for services like HIV testing and counseling and voluntary medical male circumcision. During the intervention development phase, Risi et al. found that men, particularly father-in-laws and husbands, played an important role in decision-making related to Pap smear uptake in South Africa [31]. Finding ways to meaningfully engage with male partners and relatives may therefore be an effective approach to increasing cervical screening in women. A review of barriers to cervical cancer screening in low-and-middle income countries found that lack of family support was the most commonly reported sociocultural/religious barrier [34]. Indeed, control group participants in one of our included studies, set in Ibadan, Nigeria, reported lack of support from husband (35%) and lack of decision-making ability (37%) as barriers to screening [29]. When executed strategically and sensitively, positive male partner engagement has proven valuable for promotion of other health behaviors such as adoption of HIV prevention behavior following couples-based counseling, testing, and services [39,40,41]. Male partner involvement has also shown to effect cervical cancer-related behavior change; in Uganda, male partner involvement reduced loss-to-follow-up among women referred for colposcopy [42].

Screening methods

In this review, we considered uptake of any type of cervical screening as the behavior of interest, but a question remains as to whether screening with different methodologies is one behavior or multiple behaviors. Is the behavior of screening with Pap smear truly the same as accepting visual inspection with acetic acid (VIA) or HPV testing? While some behavioral change constructs, like knowledge of cervical cancer, are shared between screening methodologies, attitudes toward each screening method may differ. For example, Adamu et al. found that 38.4% of their intervention group did “not like Pap smear” post-intervention [16]. Interestingly, this figure was much higher than at baseline when only 6.7% of the intervention group and 1.3% of the control group indicated a dislike for the test. In contrast, HPV self-sampling interventions in Nigeria and Uganda where more than 90% of self-sample kits were returned for testing were very favorably responded to by participants not only in terms of screening behavior but also in self-reported attitudes toward the screening procedure [27, 28]. When asked, 83.2% of women in one study indicated a preference for self-sampling in the future, while 9.2% preferred hospital-sampling, and 7.6% had no preference [27]. Among the women with a preference for self-sampling, they liked the test’s comfort (87%), privacy (6.5%), and found it to be less embarrassing (6.5%) [27]. To women, the act of collecting a cervicovaginal swab in the comfort of their own home may be conceptualized very differently than presenting on an exam table and exposing themselves to a health worker for a cervical exam. Future investigation into women’s conceptualization of each type of screening may inform behavior change interventions targeting each type of screening. Additionally, we recommend transparency of screening methods in reporting; one limitation we encountered was an inability to deduce the type of screening in five of the included studies (26.3%) [16, 22, 28, 29, 32].

In this review, screening uptake was highest among all screening methods for HPV testing of self-collected samples. Screen-and-treat recommendations favor use of HPV testing either alone or in sequence with other screening methods when feasible to identify high-risk, HPV-positive women [10]. Of the four studies in this review that used HPV testing, two studies referred HPV-positive women for VIA as a sequential screening method [28] or to determine treatment eligibility [23], while the remaining studies vaguely described follow-up that included inviting HPV-positive women for further investigation and treatment if necessary [19, 27]. One advantage of using HPV testing is that it frees up the screening program staff to spend more time with high-risk patients by triaging out the HPV-negative women. This screening method may, however, be more prone to loss-to-follow-up (LFU) than visual inspection screening methods. In particular, the out-of-facility location of testing possible with the method, the possible extra step added to a screen-and-treat approach, and test results that are not immediately available to health workers and women create opportunity for LFU. The endpoint or outcome of public health significance may therefore not be just the proportion of women who return a sample, but those who are notified and counseled on their results, and the number of women who go on to receive subsequent complementary cervical screening or treatment. Moses et al. utilized home- and workplace-based HPV self-sampling but found that 53.4% of the HPV-positive women in their sample were unable to be reached by phone after three attempts by the community outreach worker and ultimately 45.2% attended a follow-up VIA appointment at the health center [28]. Huchko et al. observed low treatment acquisition of HPV-positive women identified through their community health campaigns (39.2%) but observed an even lower treatment acquisition rate among women who were tested for HPV in facilities (31.5%), demonstrating that the challenge isn’t necessarily about getting women into the clinic [23]. They describe a long time between screening and treatment, 47 days on average with no difference between the study arms, as one area for LFU improvement. Other recommendations include improved follow-up protocols, use of varied result notification methods like text or in-person home-visits, and having women program the caller’s phone number into their phone at time of sample collection so that they will recognize the caller’s number later at time of notification [28]. The “screen-and-treat” approach common in Africa keeps LFU at a minimum by performing the screening, sharing the results, and treating any possible pre-cancerous lesions during the same health visit. Approaches that use HPV testing should be especially aware of LFU and proactively work to mitigate its effects.

Urban/rural divide

This review highlights greater gains in screening uptake following intervention in rural communities compared with urban study settings. Community awareness about cervical cancer and screening and access to screening may be lower in rural communities at baseline. One study found that only 10% of rural women had heard of cervical screening before and “good knowledge” increased from 2 to 70.5% following intervention [15]. The intervention by Chigbu et al., that increased screening from 3.2 to 67.6%, noted that of the women who were screened following intervention, 94.3% were not aware of cervical screening before the intervention [18]. One study included in this review operated in both urban and rural locations and further demonstrates the urban/rural difference in screening; participants in the SMS behavior change communication intervention with eVoucher for transportation had a more pronounced effect in the rural community than urban community (AOR: 8.78 vs. AOR: 4.67) [20]. Dramatic results in communities previously unexposed to information about screening and with underdeveloped health services may not be indicative of sustained increases in uptake or comparable to what is possible for urban sites. Still, screening even just once in a lifetime is beneficial and the WHO recommends increasing population coverage over increasing the number of times an individual woman is screened [10].

This is the first study, to our knowledge, to review literature on interventions to increase uptake of cervical screening in sub-Saharan Africa, a region with cervical cancer epidemiology distinct from other world regions and from other low-and-middle income countries. We apply a health behavior model to understand how interventions might work and identify opportunities for future research on cervical screening. Rigorous methodology for systematic searching, screening, and data charting and use of PRISMA-ScR reporting maximizes the review’s reproducibility.

Limitations

One limitation of this review is that 14 of 19 studies come from just two countries, Nigeria and South Africa. While we are attempting to draw conclusions at a regional level for sub-Saharan Africa, the lack of diversity in countries may limit the generalizability of findings. Still, a variety of settings and populations were represented from studies within those two countries and one study compared “diagonal” interventions across countries, juxtaposing results from South Africa to those from Mozambique and Kenya [24]. Careful construction of a search strategy that utilized individual country names for all SSA countries mitigated the possibility that South African studies would be returned more often than other countries for search terms like “Africa”. Rather, we believe that studies from these two countries are just more present in the literature. As a U.S.-based research team, we also acknowledge potential bias in the literature sources searched which may not fully capture the breadth of African literature. Missed citations could exist in Africa-specific databases or journals that we did not hand-search.

Our search may have an over-representation of Pap smear screening because of the study designs and locations of included studies. Pap smear may be seen as a gold standard for screening and may therefore be employed by RCTs and quasi-experimental studies. Pap smears may also be more widely available in certain countries like South Africa. Another review of cervical cancer prevention in sub-Saharan Africa found that VIA was the most commonly used secondary screening method [35]. Both VIA and HPV testing have been declared strategies for closing the cancer divide between LMIC and high-income countries because of their cost-effectiveness and feasibility [43] so the over-representation of Pap smear testing in our study may limit the generalizability and significance of our findings. Lastly, heterogeneity of screening methods, screening uptake measures, and lack of validated measures for secondary outcomes made it difficult to compare results across studies. Work to validate cervical cancer awareness, knowledge, attitude, belief, and personal agency measures should be undertaken in sub-Saharan Africa.

Conclusions

While educational interventions acting on one’s knowledge and skills to perform the behavior of cervical screening were the most common type of interventions identified in our review, they were minimally effective. The exception were interventions utilizing peer educators, mHealth interventions, and strategies that acted on multiple constructs from the IBM like education and environmental constraints simultaneously. Innovative approaches to cervical cancer screening service delivery, including community-based HPV self-sampling, demonstrated promising changes to uptake in screening. However, a different type of theoretical framework may be better suited to evaluate health systems change interventions. The IBM’s central premise, that intention to perform behavior is the major determinant of behavior change, was not supported by the studies in our review. We call for improved reporting of screening methods and screening outcomes including “willingness to screen” by other researchers. We also suggest further investigation into strategies that engage male partners and family members, and measurement and manipulation of personal agency to overcome barriers to screening.

Availability of data and materials

Not applicable.

Abbreviations

IBM:

Integrated Behavioral Model

HIV:

Human Immunodeficiency Virus

HPV:

Human papillomavirus

LMIC:

Low-and-middle-income countries

LFU:

Loss-to-follow-up

PICO:

Population, intervention, comparison, outcome

PRISMA-ScR:

Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews

RCT:

Randomized controlled trial

SSA:

Sub-Saharan Africa

VIA:

Visual inspection with acetic acid

VILI:

Visual inspection with Lugol’s iodine

References

  1. 1.

    De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31(Suppl 5):F32–46.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100(3):191–9.

    Article  PubMed  Google Scholar 

  4. 4.

    Anyangwe SC, Mtonga C. Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa. Int J Environ Res Public Health. 2007;4(2):93–100.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006;24(Suppl 3):S3/71–7.

    Google Scholar 

  6. 6.

    Louie KS, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical Med Int Health. 2009;14(10):1287–302.

    Article  Google Scholar 

  7. 7.

    Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F47–52.

    PubMed  Article  Google Scholar 

  8. 8.

    Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017;26(1). https://doi.org/10.1111/ecc.12444.

  9. 9.

    Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African organisation for research and training in Cancer. Lancet Oncol. 2013;14(4):e142–51.

    PubMed  Article  Google Scholar 

  10. 10.

    World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organ. 2013.

  11. 11.

    Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616.

    Article  Google Scholar 

  12. 12.

    Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69. https://doi.org/10.1186/1748-5908-5-69.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

    PubMed  Article  Google Scholar 

  14. 14.

    Montano DE, Kasprzyk D. Theory of reasoned action, theory of planned behavior, and the integrated behavioral model. Health Behavior. 2015;70(4):231.

    Google Scholar 

  15. 15.

    Abiodun OA, Olu-Abiodun OO, Sotunsa JO, Oluwole FA. Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Adamu AN, Abiola AO, Ibrahim M. The effect of health education on the knowledge, attitude, and uptake of free pap smear among female teachers in Birnin-Kebbi, North-Western Nigeria. Niger J Clin Pract. 2012;15(3):326–32.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Adonis L, Paramanund J, Basu D, Luiz J. Framing preventive care messaging and cervical cancer screening in a health-insured population in South Africa: implications for population-based communication? J Health Psychol. 2017;22(11):1365–75.

    PubMed  Article  Google Scholar 

  18. 18.

    Chigbu CO, Onyebuchi AK, Onyeka TC, Odugu BU, Dim CC. The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria. Int J Gynaecol Obstet. 2017;137(3):319–24.

    PubMed  Article  Google Scholar 

  19. 19.

    Dreyer G, van der Merwe FH, Botha MH, Snyman LC, Constant D, Visser C, et al. School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening. S Afr Med J. 2015;105(11):912–6.

    PubMed  Article  Google Scholar 

  20. 20.

    Erwin E, Aronson KJ, Day A, Ginsburg O, Macheku G, Feksi A, et al. SMS behaviour change communication and eVoucher interventions to increase uptake of cervical cancer screening in the Kilimanjaro and Arusha regions of Tanzania: a randomised, double-blind, controlled trial of effectiveness. BMJ Innovations. 2019;5(1):28–34.

  21. 21.

    Gana GJ, Oche MO, Ango JT, Kaoje AU, Awosan KJ, Raji IA. Educational intervention on knowledge of cervical cancer and uptake of Pap smear test among market women in Niger State, Nigeria. J Public Health Afr. 2017;8(2):111–16.

  22. 22.

    Hewett PC, Nalubamba M, Bozzani F, Digitale J, Vu L, Yam E, et al. Randomized evaluation and cost-effectiveness of HIV and sexual and reproductive health service referral and linkage models in Zambia. BMC Public Health. 2016;16:785.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Huchko MJ, Ibrahim S, Blat C, Cohen CR, Smith JS, Hiatt RA, et al. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. Int J Gynaecol Obstet. 2018;141(1):63–9.

    PubMed  Article  Google Scholar 

  24. 24.

    Lafort Y, Greener L, Lessitala F, Chabeda S, Greener R, Beksinska M, et al. Effect of a 'diagonal' intervention on uptake of HIV and reproductive health services by female sex workers in three sub-Saharan African cities. Tropical Med Int Health. 2018;23(7):774–84.

    Article  Google Scholar 

  25. 25.

    Mbachu C, Dim C, Ezeoke U. Effects of peer health education on perception and practice of screening for cervical cancer among urban residential women in south-East Nigeria: a before and after study. BMC Womens Health. 2017;17(1):41.

    PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Mehrotra A, An R, Patel DN, Sturm R. Impact of a patient incentive program on receipt of preventive care. Am J Manag Care. 2014;20(6):494–501.

    PubMed  PubMed Central  Google Scholar 

  27. 27.

    Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, de Koning M, et al. Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infect Agent Cancer. 2017;12:11.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  28. 28.

    Moses E, Pedersen HN, Mitchell SM, Sekikubo M, Mwesigwa D, Singer J, et al. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. Tropical Med Int Health. 2015;20(10):1355–67.

    CAS  Article  Google Scholar 

  29. 29.

    Ndikom CM, Ofi BA, Omokhodion FO, Adedokun BO. Effects of educational intervention on women’s knowledge and uptake of cervical cancer screening in selected hospitals in Ibadan, Nigeria. Int J Health Promot Educ. 2017;55(5–6):259–71.

    Article  Google Scholar 

  30. 30.

    Okeke EN, Adepiti CA, Ajenifuja KO. What is the price of prevention? New evidence from a field experiment. J Health Econ. 2013;32(1):207–18.

    PubMed  Article  Google Scholar 

  31. 31.

    Risi L, Bindman JP, Campbell OM, Imrie J, Everett K, Bradley J, et al. Media interventions to increase cervical screening uptake in South Africa: an evaluation study of effectiveness. Health Educ Res. 2004;19(4):457–68.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Rosser JI, Njoroge B, Huchko MJ. Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: the effects of an educational intervention in rural Kenya. Patient Educ Couns. 2015;98(7):884–9.

    PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Wright KO, Faseru B, Kuyinu YA, Faduyile FA. Awareness and uptake of the pap smear among market women in Lagos, Nigeria. J Public Health Afr. 2011;2(1):e14.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Devarapalli P, Labani S, Nagarjuna N, Panchal P, Asthana S. Barriers affecting uptake of cervical cancer screening in low and middle income countries: a systematic review. Indian J Cancer. 2018;55(4):318–26.

    PubMed  Article  Google Scholar 

  35. 35.

    Johnson LG, Armstrong A, Joyce CM, Teitelman AM, Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review. Implement Sci. 2018;13(1):28.

    PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev. 2011;5:CD002834.

    Google Scholar 

  37. 37.

    Spadea T, Bellini S, Kunst A, Stirbu I, Costa G. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med. 2010;50(4):159–64.

    PubMed  Article  Google Scholar 

  38. 38.

    Rees I, Jones D, Chen H, Macleod U. Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: a systematic review. Prev Med. 2018;111:323–35.

    PubMed  Article  Google Scholar 

  39. 39.

    Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet. 2000;356(9224):103–12.

  40. 40.

    Jones DL, Ross D, Weiss SM, Bhat G, Chitalu N. Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women. J Urban Health. 2005;82(3 Suppl 4):iv92–100.

    PubMed  Google Scholar 

  41. 41.

    Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;37(5):1620–6.

    PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Mutyaba T, Mirembe F, Sandin S, Weiderpass E. Male partner involvement in reducing loss to follow-up after cervical cancer screening in Uganda. Int J Gynaecol Obstet. 2009;107(2):103–6.

    PubMed  Article  Google Scholar 

  43. 43.

    Denny L, de Sanjose S, Mutebi M, Anderson BO, Kim J, Jeronimo J, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2017;389(10071):861–70.

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Purnima Madhivanan PhD, MBBS, MPH was funded by NIH grant # D43 TW010540 and R15-AI28714–01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Affiliations

Authors

Contributions

The review concept was conceived by BEL, PA, and JE. The search strategy including identification of search terms and electronic databases were developed by BEL and JMC. The search was conducted jointly by BEL and JMC. Three reviewers, BEL, MJT, and CB, independently screened search results. BEL charted data from included studies and data charting was checked for accuracy by MJT and CB. BEL drafted all sections of the review. All authors read the manuscript, provided feedback, and approved of the final draft (BEL, MJT, CB, PA, PM, SC, KE, JE).

Corresponding author

Correspondence to Breanne E. Lott.

Ethics declarations

Ethics approval and consent to participate

No ethics approval or consent were obtained since this is a review of previously published peer-reviewed articles and no new participant data is used or reported.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Appendix 1. Complete systematic searches conducted on May 1st, 2019. This appendix presents the comprehensive search strategy for all electronic databases searched (PubMed, Web of Science, Embase, CINAHL) with controlled vocabulary and key terms, as well as the number of search results returned.

Additional file 2.

Lott_PRISMA-ScR Checklist. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist. Completed checklist for the scoping review, using the PRISMA Extension for Scoping Reviews.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lott, B.E., Trejo, M.J., Baum, C. et al. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model. BMC Public Health 20, 654 (2020). https://doi.org/10.1186/s12889-020-08777-4

Download citation

Keywords

  • Cervical cancer
  • Screening
  • Secondary prevention
  • Review
  • Sub-Saharan Africa
  • Health behavior